Last week, the National Football League approved a settlement that would issue payments to injured players after the league failed to properly investigate and respond to concussion-causing hits. However, a big slice of the payments will instead go to the players' health insurers.
Even as the White House has unveiled an aggressive, $1.2 billion plan to fight antibiotic-resistant infections, a new study suggests that U.S. hospitals don't do enough to prevent one particularly dangerous superbug from harming patients.
Blue Shield of California's former Chief Technology Officer Aaron Kaufman remains on the hot seat after details emerged last week that he spent more than $100,000 on his corporate credit card. Kaufman was fired in March for alleged violations of Blue Shield's travel and expense policies.
Healthcare is already changing before hospital leaders' eyes, but several longer-term trends will emerge over the next five to 15 years, healthcare experts told the Healthcare Financial Management Association.
In this special report, FierceHealthFinance takes a look at why some hospital merger and acquisitions don't work so healthcare leaders can avoid making the same mistakes.
The use of a drug called spice--a synthetic substance that mimics the effects of marijuana--has sparked a troubling rise in visits to emergency departments and calls to poison control, the New York Times reports.
In a report that puts hard numbers behind a danger many health workers have long spoken out against, the Occupational Health Safety Network found that injuries associated with workplace violence increased overall from 2012 to 2014 and "nearly doubled for nurse assistants and nurses."
Congressional Republicans are mulling whether to allow individuals to keep their Affordable Care Act federal subsidies until 2017.
U.S. Surgeon General Vivek Murthy, M.D., called for improving public health by creating a "prevention-based society" in an interview with the Washington Post.
As controversy continues to swirl around superbug outbreaks in U.S. hospitals, a new study sounds the alarm that shortages of key antibiotics could make drug-resistant bacteria an even bigger threat to patients.